Heron Therapeutics Inc. (HRTX) announced Loss for first quarter that decreased from the same period last year and beat the Street estimates.
The company's earnings totaled -$3.16 million, or -$0.02 per share. This compares with -$32.77 million, or -$0.27 per share, in last year's first quarter.
Analysts on average had expected the company to earn -$0.09 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 17.0% to $34.67 million from $29.62 million last year.
Heron Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$3.16 Mln. vs. -$32.77 Mln. last year.
-EPS (Q1): -$0.02 vs. -$0.27 last year.
-Revenue (Q1): $34.67 Mln vs. $29.62 Mln last year.
-Guidance:
Full year revenue guidance: $138 Mln-$158 Mln
For comments and feedback contact: editorial@rttnews.com